mots-c vs aod9604 AOD-9604 | A Comparative Analysis Aod Peptide Vs Mots C

Short-Term Changes (2026) Additional Category 2 Designations : The FDA continues reviewing peptides for potential Category 2 addition

Larger shipments or those flagged by intelligence face seizure

Every component ships with its lot-matched COA

This 503C designation would require enhanced quality controls beyond 503A standards but less infrastructure than 503B facilities

A US-licensed nurse practitioner or physician reviews your intake and, if Lean Stack (AOD-9604/MOTs-C/Tesamorelin/Ipamorelin) is appropriate for you, writes a patient-specific prescription

Misbranding and Mislabeling Selling research peptides while making or implying human use claims constitutes misbranding under federal law